One of the greatly understudied areas in diabetes translational research is determining how to care for older people with diabetes. Despite the fact that 40% of people with type 2 diabetes are 65 years of age or older, little research has been devoted to identifying how to ideally account for the heterogeneity of this population when developing diabetes care plans. The CCDTR is a leading national center for the study of geriatric diabetes.
The purpose of this longitudinal study is to understand the state of geriatric diabetes care and disease burden within an aging multi-ethnic population. Learn more
The purpose of the NSHAP study is to understand the well-being of older, community-dwelling Americans. Findings from this study will contribute to implementation of effective practices that improve health as people age. Learn more
This is a pilot study that will compare the validity of physician-predicted and model-predicted five-year survival of older patients with type 2 diabetes. In hopes to better inform clinical decision making we have developed a decision analytic model, the Chicago Type 2 Geriatric Diabetes Model that predicts life expectancy and complications related to diabetes. Establishing the validity of the simulation model will be crucial to the future design of prognostic tool interventions for clinical practice. Learn more